{"product_id":"portfolio-program-and-project-management-in-the-pharmaceutical-and-biotechnology-industries-hardback-9780470049662","title":"Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries (Hardback) 9780470049662","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePortfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003ePete Harpum (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780470049662, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 16 April 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e352 pages\u003cbr\u003e21.8 x 15.8 x 1.3 cm, 0.635 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eAcknowledgments xi\u003c\/p\u003e \u003cp\u003eAbout the Authors xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart One The Life Science Industry Context for Portfolio, Program, and Project Management\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. A Review of Project Management in Life Science Industry Sectors 3\u003cbr\u003e\u003ci\u003eThomas R. Dunson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2. The Impact of Organizational Size on Drug Project Management 21\u003cbr\u003e\u003ci\u003eEric Morfin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3. Drug Development in Biotechnology and How We Can Do It Better 33\u003cbr\u003e\u003ci\u003eSusan Linna\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Two The Portfolio, Program, and Project Management Approaches and Processes\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e4. An Overview of the Organization and Processes of Portfolio, Program, and Project Management 53\u003cbr\u003e\u003ci\u003ePete Harpum\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5. Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market 59\u003cbr\u003e\u003ci\u003eJohn Bennett\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6. Program Management in Drug Development 85\u003cbr\u003e\u003ci\u003ePauline Stewart-Long\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. Project Control 101\u003cbr\u003e\u003ci\u003eMartin Powell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8. Managing Uncertainty in Drug Projects 135\u003cbr\u003e\u003ci\u003ePete Harpum and Thomas R. Dunson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. Managing Drug Safety Risk 155\u003cbr\u003e\u003ci\u003eThomas R. Dunson and Eric Morfin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. Developing Program Strategy 175\u003cbr\u003e\u003ci\u003ePete Harpum\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11. Developing Products with “Added Value” 197\u003cbr\u003e\u003ci\u003eTrevor J. Brown and Stephen Allport\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart Three Integrating the Processes\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e12. Integrated Business Processes to Support Cross-Functional Drug Development 227\u003cbr\u003e\u003ci\u003eMartin D. Hynes III\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13. Integrated Drug Development: From Cradle to Grave and from Lab to Market 239\u003cbr\u003e\u003ci\u003eStephen Allport and Terry Cooke-Davies\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14. The Development of P3M Capability in Drug Development Organizations 259\u003cbr\u003e\u003ci\u003eJohn Arrowsmith, Patrick Grogan, and Bob Moore\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations 287\u003cbr\u003e\u003ci\u003ePete Harpum, Ashley Jamieson, and Inge Fisher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eBibliography 311\u003c\/p\u003e \u003cp\u003eIndex 313\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Chemistry [\u003ca title=\"See our other books on Chemistry\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Chemistry%20%5BPN%5D%22\"\u003ePN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52501083357464,"sku":"9780470049662","price":94.29,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780470049662.jpg?v=1786208869","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/portfolio-program-and-project-management-in-the-pharmaceutical-and-biotechnology-industries-hardback-9780470049662","provider":"Freshly Printed Books","version":"1.0","type":"link"}